|
 |
| Many companies
investing heavily in the genomics area are recognizing the
need to incorporate proteomic technologies into their
product mix. CHI has developed the Protein and Proteomics
conference series to help organizations understand what new
technologies and applications are revolutionizing this
emerging field. Typically, topic areas include coverage of
protein-protein interaction, protein expression, protein
arrays, and proteomic technologies. The emphasis on
breakthrough technologies coupled with a focus on the
commercial implications of the technology, particularly for
drug development, will assist organizations in maximizing
their results now and in the future.
|
|
|
|
PEGS
2007
Phage Display Therapeutics
Difficult to Express Proteins
Engineering Proteins for Delivery
Recombinant Antibodies
Monoclonal Antibodies
Executive Summit
|
|
|
|
|
